Geraniin as a potential inhibitor of SARS-CoV-2 3CL<sup>pro</sup>.

Yu, Wen-Di; Jin, Qi-Ying; Zeng, Mao-Sen; Liu, Jin-Yuan; Xu, Pei-Ping

Geraniin as a potential inhibitor of SARS-CoV-2 3CL^pro.

Yu, Wen-Di; Jin, Qi-Ying; Zeng, Mao-Sen; Liu, Jin-Yuan; Xu, Pei-Ping.

Afiliación

Yu WD; Institute of Tropical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, P.R. China.
Jin QY; Institute of Tropical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, P.R. China.
Zeng MS; Institute of Tropical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, P.R. China.
Liu JY; Basic Medical College, Guangzhou University of Chinese Medicine, Guangzhou, P.R. China.
Xu PP; Institute of Tropical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, P.R. China.

Nat Prod Res ; 36(23): 6060-6063, 2022 Dec.

Article en En | MEDLINE | ID: mdl-35200071

Asunto(s)

Tratamiento Farmacológico de COVID-19; SARS-CoV-2; Humanos; Proteasas 3C de Coronavirus; Simulación del Acoplamiento Molecular; Cisteína Endopeptidasas

Palabras clave

Geraniinï¼HCoV-OC43 coronavirusï¼Main protease (Mpro/3CLpro)ï¼ Molecular docking and simulationï¼SARS-CoV-2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Nat Prod Res Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google